MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-UP-29-0067889
Sunflex Remedies Private Limited
Sunflex Remedies Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹33.59 Lakh
▼ 14% YoY
Net profit · FY 2025
₹3,835
Net margin 0.1%
EBITDA · FY 2025
₹41,041
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.02 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Sunflex Remedies Private Limited
Data last updated:
Sunflex Remedies Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51900DL2019PTC354689. Its GSTIN is 09ABCCS5901N1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.02 Lakh. It is led by directors including Shobhit Sharma and Upendra Singh Kushwaha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.190/A – 1 Kh. No. 74/15 1st Floor Naveen Village Begampur, New Delhi, Delhi, India – 110081.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.59 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹3,835 (net margin 0.1%) and EBITDA of ₹41,041 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years.
Sunflex Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0067889).
Company details
CIN U51900DL2019PTC354689
Registration Number 354689
Incorporation Date 04 September 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0067889
Recognitions & Rankings of Sunflex Remedies
Contact details
Sunflex Remedies Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.190/A – 1 Kh. No. 74/15 1st Floor Naveen Village Begampur, New Delhi, Delhi, India – 110081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunflex Remedies Private Limited, buy the company report.
Comprehensive company report
Sunflex Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sunflex Remedies is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Sunflex Remedies Private Limited, buy the company report.
Financials of Sunflex Remedies Private Limited
FY 2025 filings availableSunflex Remedies Private Limited reported revenue of ₹33.59 Lakh (down 14% YoY) for FY 2025.
Revenue · FY 2025
₹33.59 Lakh ▼ 14%
Net profit · FY 2025
₹3,835 margin 0.1%
EBITDA · FY 2025
₹41,041 margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 30%
5 years · compounded
▲ 50%
Revenue fell 14% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41,041 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,835 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunflex Remedies Private Limited, buy the company report.
Board of directors of Sunflex Remedies Private Limited
Sunflex Remedies has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobhit Sharma | Director | 04 Sep 2019 | 7 Years 2 Months | Current |
| Upendra Singh Kushwaha | Director | 04 Sep 2019 | 7 Years 2 Months | Current |
| Amit Kumar Sharma | Director | 04 Sep 2019 | 7 Years 2 Months | Current |
Auditor
Sunflex Remedies Private Limited is audited by GSPT & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GSPT & ASSOCIATES LLP | FY 2023 | 029722N |
Shareholding
The shareholding of Sunflex Remedies Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sunflex Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunflex Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunflex Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunflex Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABCCS5901N1ZZ | Uttar Pradesh | Active | 04 Oct 2019 |
To see the full GST registrations and return filing status of Sunflex Remedies Private Limited, buy the company report.
Recent activity
Sunflex Remedies Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Amit Kumar Sharma was appointed as Director on 04 Sep 2019.
AGM
Sunflex Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sunflex Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Amit Kumar Sharma was appointed as Director.
Appointed
Shobhit Sharma was appointed as Director.
Appointed
Upendra Singh Kushwaha was appointed as Director.
Incorporation
04 Sep 2019
Sunflex Remedies Private Limited was registered on 04 Sep 2019 with Roc Delhi & aged 7 years 2 months as per MCA records.
Frequently asked questions
Sunflex Remedies is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2019 (7+ years old) and is registered under CIN U51900DL2019PTC354689.
Sunflex Remedies has 3 current directors:
- Shobhit Sharma - Director
- Upendra Singh Kushwaha - Director
- Amit Kumar Sharma - Director
The latest financial statements of Sunflex Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sunflex Remedies is 09ABCCS5901N1ZZ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sunflex Remedies is U51900DL2019PTC354689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunflex Remedies was incorporated on 04 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Kumar Sharma was appointed as Director on 04 Sep 2019. Shobhit Sharma was appointed as Director on 04 Sep 2019. Upendra Singh Kushwaha was appointed as Director on 04 Sep 2019.
Yes, Sunflex Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0067889).
The registered office of Sunflex Remedies is at Plot No.190A – 1 Kh. No. 7415 1st Floor Naveen Village Begampur, New Delhi, Delhi, India – 110081.
Sunflex Remedies operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages